Myocardial infarction (MI) is a
cardiovascular disease with high
morbidity and
mortality, which seriously endangers
human health. Poor ways of repair after MI may damage people's
life quality, therefore scientists have been committed to exploring the way of myocardial repair after MI to strive for a better
prognosis of these
patients.
Chinese patent medicines for
blood circulation activation have a long
history of use in
treatment of MI, where they have been shown to attenuate myocardial
injury after MI and promote cardiac repair with multiple targets, links and pathways. This
review focuses on a few representative
Chinese patent medicines for MI and summarizes their pharmacological effects and clinical
research in cardiac repair following MI, effectively providing scientific
foundation on treating MI with
Chinese patent medicines.